313 results on '"Klot, Christoph"'
Search Results
2. Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy
3. Moderately HRT vs. CRT for localized prostate cancer using image-guided VMAT with SIB: evaluation of acute and late toxicities
4. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
5. Real-World experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study
6. Comparison of 68 Ga-PSMA ligand PET/CT versus conventional cross-sectional imaging for target volume delineation for metastasis-directed radiotherapy for metachronous lymph node metastases from prostate cancer
7. Künstliche Intelligenz und neuronale Netze in der Urologie
8. ShinyLUTS—A Shiny web application for structured data management and analysis for patients with lower urinary tract symptoms (LUTS)
9. Medikamentöse Therapie des metastasierten Nierenzellkarzinoms
10. Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)
11. PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer
12. Patterns of relapse as determined by 68Ga-PSMA ligand PET/CT after radical prostatectomy: Importance for tailoring and individualizing treatment
13. Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer
14. Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence after primary therapy for prostate cancer
15. 68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer
16. Cushing’s Syndrome
17. Dysuria
18. Using a Further Planning MRI after Neoadjuvant Androgen Deprivation Therapy Significantly Reduces the Radiation Exposure of Organs at Risk in External Beam Radiotherapy of Prostate Cancer
19. Rezum water vapor thermal therapy for treatment of lower urinary tract symptoms: A retrospective single-centre analysis from a German high-volume centre
20. True Incidence of Gleason 6 Pathology in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
21. Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study
22. 68Ga-PSMA I&T PET/CT for assessment of prostate cancer: evaluation of image quality after forced diuresis and delayed imaging
23. 68Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer: Early efficacy after primary therapy
24. Perinephric Toxic Fat: Impact on Surgical Complexity, Perioperative Outcome, and Surgical Approach in Partial Nephrectomy
25. Apoptosis gene polymorphisms and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy
26. Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients
27. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor
28. Long-term bowel disorders following radial cystectomy: an underestimated issue?
29. Prediction of Perioperative Death Following Surgery for Renal Cell Carcinoma with Vein Involvement: A Retrospective Study
30. Decreased mRNA expression of GATA1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma
31. Laparoendoscopic partial nephrectomy in single-incision triangulated umbilical surgery (SITUS) technique: Early experience
32. The Prognostic Value of Liquid Biopsies for Benefit of Salvage Radiotherapy in Relapsed Oligometastatic Prostate Cancer
33. Combination of PI-RADS score and mRNA urine test—A novel scoring system for improved detection of prostate cancer
34. PD33-11 IMPACT OF ADHESIVE PERINEPHRIC FAT ON SURGICAL PLANNING AND PERIOPERATIVE OUTCOMES IN PARTIAL NEPHRECTOMY
35. First experiences and results after cryoablation of prostate cancer with histopathological evaluation and imaging-based follow-up
36. Is there an anti-androgen withdrawal syndrome for enzalutamide?
37. Superiority of the EF-120-00-3F biopsy forceps in the histopathological evaluation of upper urinary tract specimens
38. Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer
39. Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case report
40. Perinephric Toxic Fat: Impact on Surgical Complexity, Perioperative Outcome, and Surgical Approach in Partial Nephrectomy.
41. RLC score (R status, lymphovascular invasion, C-reactive protein) predicts survival following radical cystectomy for muscle-invasive bladder cancer.
42. Incidence of synchronous and metachronous adrenal metastases following tumor nephrectomy in renal cell cancer patients: a retrospective bi-center analysis
43. Age Distribution for Partial and Radical Nephrectomy: Whose Nephrons are Being Spared?
44. Medikamentöse Therapie des metastasierten Nierenzellkarzinoms
45. THE TNR-C SCORE QUALIFIES AS A PROGNOSTIC TOOL FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY: RESULTS OF AN EXTERNAL VALIDATION: PD18-10
46. A NEW OUTCOME PREDICTION MODEL FOR PATIENTS UNDERGOING RADICAL CYSTECTOMY BASED ON PREOPERATIVE PARAMETERS: PD18-11
47. Additional file 2 of DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
48. Additional file 1 of DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
49. Urinary tract injuries in patients with multiple trauma
50. Comment on: “Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.